Bausch Health Companies (BHC) Net Margin (2009 - 2026)
Bausch Health Companies (BHC) posted Net Margin of 9.12% for Q2 2026, up 116.08% sequentially from 56.7% in Q1 2026, and up 406.0% YoY from 1.8% in Q2 2025.
Bausch Health Companies (BHC) Net Margin (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Net Margin for 18 years, with the latest figure at 9.12% in Q2 2026.
- Quarterly Net Margin rose 406.0% year-over-year to 9.12% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 10.07% (down 1056.0% YoY) and the FY2025 annual result came in at 1.17%, up 192.0% from the prior year.
- Net Margin advanced to 9.12% in Q2 2026 per BHC's latest filing, from 56.7% in the prior quarter.
- Over five years, Net Margin peaked at 19.7% in Q3 2022 and troughed at 56.7% in Q1 2026.
- A 5-year average of 4.71% and a median of 3.51% in 2022 frame the typical range for Net Margin.
- The sharpest annual moves came in 2022 and 2026: Net Margin jumped 2650 bps in 2022, then sank 5289 bps in 2026.
- Over 5 years, Net Margin stood at 18.7% in 2022, then surged by 90 bps to 1.95% in 2023, then jumped by 296 bps to 3.83% in 2024, then sank by 196 bps to 3.68% in 2025, then soared by 347 bps to 9.12% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 9.12%, 56.7%, and 3.68% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Bausch Health Companies | 2.56 Bn | 725.13 Mn | 2.10 Bn | 9.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.12% |
| Mar 31, 2026 | -56.70% |
| Dec 31, 2025 | -3.68% |
| Sep 30, 2025 | 6.75% |
| Jun 30, 2025 | 5.06% |
| Mar 31, 2025 | -3.81% |
| Dec 31, 2024 | 3.83% |
| Sep 30, 2024 | -3.67% |
| Jun 30, 2024 | -0.04% |
| Mar 31, 2024 | -3.58% |
| Dec 31, 2023 | -1.95% |
| Sep 30, 2023 | -17.07% |
| Jun 30, 2023 | 1.25% |
| Mar 31, 2023 | -10.75% |
| Dec 31, 2022 | -18.70% |
| Sep 30, 2022 | 19.70% |
| Jun 30, 2022 | -7.07% |
| Mar 31, 2022 | -3.44% |
| Dec 31, 2021 | 0.99% |
| Sep 30, 2021 | 9.05% |